Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive Effects of Aripiprazole in Children with ADHD
NCT00221962Phase 4Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Apr 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aripiprazole in attention deficit hyperactivity disorder (ADHD), sponsored by University Hospitals Cleveland Medical Center. Primary endpoints: Effectiveness at 6 weeks and Cognitive effects at 6 weeks. Started Apr 2005; status: completed.
02
Drugs
aripiprazole
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00221962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221962.